MMP9 and prostate adenocarcinoma: The latter was clearly demonstrated by an experiment in immunocompromised mice in which host MMP-9 status significantly affected growth of transplanted osteolytic/osteogenic-inducing prostate adenocarcinoma in the calvaria [77].